2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

mProbe Inc

Company Presentations

Friday, July 24 Company Presentations 5–Diagnostics, Device, NPO

mProbe Inc(台灣雲檢)

Company Info

Name /mProbe Inc(台灣雲檢)

Address /7F., NO.398, XINGSHAN RD., NEIHU DIST., TAIPEI CITY 11469, TAIWAN

Website /www.mprobe.com.tw

Presenter

Name /Karl Sylvester

Title /Chief Medical Officer

Company Type

Biotechnology,Artificial Intelligence,Diagnostics

About the Company

With multi-omics as the critical evidence, mProbe has endeavored to interpret that evidence against a proprietary, vast clinically annotated, library of phenotypes using artificial intelligence.

In the same way the Human Genome Project scientists came together to catalog how a specific segment related to a specific genetic expression, we are cataloging how protein and metabolite expression relates to a disease, risk of a disease, progression of a disease and response to an intervention. The availability and application of artificial intelligence and advanced data science now make it possible for us to recognize those patterns using mass spectrometry on blood samples.

The results are foundational for truly personalized health and precision medicine.

Brief Description of main products or services

Liquid Health CheckTM is a simple blood test giving providers, plans, employers or individuals insight into disease risk for avoidable conditions like hypertension, heart disease, diabetes, and kidney disease.  The comprehensive Clinical Risk Report produced in our CAP/CLIA certified laboratory provides absolute and relative risk along with predicted time to the disease event for both high and low risk cohorts.

Liquid Health BaselineTM is a phenotypical analysis for providers, plans, employers or individuals informing a comprehensive risk profile for high impact disease and events like cancers, heart disease, diabetes, preeclampsia and pre-term birth.

Contact Person

Name /Max Su

Email /maxsu@mprobe.com